Cargando…
Familial Hypercholesterolemia and Acute Coronary Syndromes: The Microbiota–Immunity Axis in the New Diagnostic and Prognostic Frontiers
Familial hypercholesterolemia is a common genetic disorder with a propensity towards early onset of atherosclerotic cardiovascular disease (CVD). The main goal of therapy is to reduce the LDL cholesterol and the current treatment generally consists of statin, ezetimibe and PCSK9 inhibitors. Unfortun...
Autores principales: | Piccioni, Andrea, Niccolai, Elena, Rozzi, Gloria, Spaziani, Giacomo, Zanza, Christian, Candelli, Marcello, Covino, Marcello, Gasbarrini, Antonio, Franceschi, Francesco, Amedei, Amedeo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142551/ https://www.ncbi.nlm.nih.gov/pubmed/37111513 http://dx.doi.org/10.3390/pathogens12040627 |
Ejemplares similares
-
Gut Microbiota and Clostridium difficile: What We Know and the New Frontiers
por: Piccioni, Andrea, et al.
Publicado: (2022) -
Microbiota and Myopericarditis: The New Frontier in the Car-Diological Field to Prevent or Treat Inflammatory Cardiomyo-Pathies in COVID-19 Outbreak
por: Piccioni, Andrea, et al.
Publicado: (2021) -
The Impact of Smoking on Microbiota: A Narrative Review
por: Cicchinelli, Sara, et al.
Publicado: (2023) -
Microbiota and Probiotics: The Role of Limosilactobacillus Reuteri in Diverticulitis
por: Piccioni, Andrea, et al.
Publicado: (2021) -
Interaction between Lipopolysaccharide and Gut Microbiota in Inflammatory Bowel Diseases
por: Candelli, Marcello, et al.
Publicado: (2021)